ATE202708T1 - Peptidantagonisten des bradykinin - Google Patents

Peptidantagonisten des bradykinin

Info

Publication number
ATE202708T1
ATE202708T1 AT92917374T AT92917374T ATE202708T1 AT E202708 T1 ATE202708 T1 AT E202708T1 AT 92917374 T AT92917374 T AT 92917374T AT 92917374 T AT92917374 T AT 92917374T AT E202708 T1 ATE202708 T1 AT E202708T1
Authority
AT
Austria
Prior art keywords
bradykinin
antagonists
produced
analogs
peptide antagonists
Prior art date
Application number
AT92917374T
Other languages
English (en)
Inventor
Donald James Kyle
Roger Neal Hiner
Original Assignee
Scios Nova Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Nova Inc filed Critical Scios Nova Inc
Application granted granted Critical
Publication of ATE202708T1 publication Critical patent/ATE202708T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92917374T 1991-04-19 1992-04-16 Peptidantagonisten des bradykinin ATE202708T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68795991A 1991-04-19 1991-04-19
US86624692A 1992-04-14 1992-04-14
PCT/US1992/003033 WO1992018156A1 (en) 1991-04-19 1992-04-16 Bradykinin antagonist peptides

Publications (1)

Publication Number Publication Date
ATE202708T1 true ATE202708T1 (de) 2001-07-15

Family

ID=27104123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92917374T ATE202708T1 (de) 1991-04-19 1992-04-16 Peptidantagonisten des bradykinin

Country Status (11)

Country Link
US (1) US5385889A (de)
EP (1) EP0618810B1 (de)
JP (1) JPH07504155A (de)
AT (1) ATE202708T1 (de)
AU (1) AU1873992A (de)
CA (1) CA2106762C (de)
DE (1) DE69231918D1 (de)
IE (1) IE921296A1 (de)
IL (1) IL101648A (de)
NZ (1) NZ242446A (de)
WO (1) WO1992018156A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686565A (en) * 1992-10-08 1997-11-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5541286A (en) * 1992-10-08 1996-07-30 Scios Nova Inc. Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
JPH11500100A (ja) * 1993-09-09 1999-01-06 サイオス ノバ インコーポレイテッド 偽ペプチドおよび非ペプチドブラジキニンレセプターアンタゴニスト
US5817756A (en) * 1993-09-09 1998-10-06 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
JPH10510540A (ja) * 1994-12-12 1998-10-13 オメロス メディカル システムズ,インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
WO1996019233A2 (en) * 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
EP0832106A2 (de) * 1995-06-05 1998-04-01 Cortech, Inc. Verbindungen mit bradykinin antagonistischen aktivität und mu-opioid agonistischen aktivität
US5891737A (en) * 1995-06-07 1999-04-06 Zymogenetics, Inc. Combinatorial non-peptide libraries
CA2221865C (en) * 1995-06-09 2007-12-11 The Regents Of The University Of Michigan Bradykinin analogs as selective thrombin inhibitors
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO1998007746A1 (en) * 1996-08-19 1998-02-26 Universite De Sherbrooke B1-bradykinin receptor antagonists and use thereof
US7041785B1 (en) 1996-08-19 2006-05-09 UNIVERSITé DE SHERBROOKE B1-bradykinin receptor antagonists and use thereof
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
GB0225379D0 (en) * 2002-10-31 2002-12-11 Pfizer Ltd Therapeutic proline derivatives
US7659305B2 (en) * 2002-10-31 2010-02-09 Pfizer Inc. Therapeutic proline derivatives
JP4631262B2 (ja) * 2003-10-07 2011-02-16 東レ・ファインケミカル株式会社 (シス)−4−ヒドロキシプロリン誘導体の製造方法
US7605120B2 (en) * 2003-10-22 2009-10-20 Amgen Inc. Antagonists of the brandykinin B1 receptor
JP2005350417A (ja) * 2004-06-11 2005-12-22 Dai Ichi Seiyaku Co Ltd 還元的エーテル化法を用いたピロリジン誘導体の製造法
WO2008119005A1 (en) * 2007-03-27 2008-10-02 Trustees Of Tufts College 3,4-dehydro-proline-containing inhibitors of dipeptidylpeptidase iv

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964956D1 (en) * 1978-07-18 1983-04-07 Kabi Ab Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them
US4483850A (en) * 1982-05-10 1984-11-20 Merck & Co., Inc. N-Terminal substituted oligopeptide converting enzyme inhibitors
DE3303112A1 (de) * 1983-01-31 1984-08-09 Hoechst Ag, 6230 Frankfurt Verfahren zur racemattrennung optisch aktiver bicyclischer imino-(alpha)-carbonsaeuren
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4801613A (en) * 1985-06-13 1989-01-31 Nova Technology Limited Partnership Bradykinin antagonist peptides
US4912231A (en) * 1987-06-15 1990-03-27 E. R. Squibb & Sons, Inc. Process for preparing (trans)-4-phenyl-L-proline derivatives
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
DE3820190A1 (de) * 1988-06-14 1989-12-21 Cassella Ag Pyrrolderivate, ihre herstellung und ihre verwendung als pharmazeutische wirkstoffe
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
US4937355A (en) * 1989-01-17 1990-06-26 E. R. Squibb & Sons, Inc. Process for preparing (trans)-4-substituted-dl-proline derivatives
DE69226708T2 (de) * 1991-04-19 1999-04-15 Scios Nova Inc., Mountain View, Calif. Bradykinin typische peptide

Also Published As

Publication number Publication date
IE921296A1 (en) 1992-10-21
JPH07504155A (ja) 1995-05-11
EP0618810B1 (de) 2001-07-04
DE69231918D1 (de) 2001-08-09
WO1992018156A1 (en) 1992-10-29
NZ242446A (en) 1994-04-27
EP0618810A4 (de) 1994-12-07
CA2106762A1 (en) 1992-10-20
US5385889A (en) 1995-01-31
IL101648A0 (en) 1992-12-30
AU1873992A (en) 1992-11-17
IL101648A (en) 1996-08-04
EP0618810A1 (de) 1994-10-12
CA2106762C (en) 2000-10-10

Similar Documents

Publication Publication Date Title
DE69231918D1 (de) Peptidantagonisten des bradykinin
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
ES2130265T3 (es) Region de union al receptor de la toxina difterica.
DE69226708D1 (en) Bradykinin typische peptide
ES2187958T3 (es) Antagonistas de gnrh.
EA199800559A1 (ru) Антагонисты гонадотропин-высвобождающего фактора
EA199800564A1 (ru) Антагонисты гонадотропин-высвобождающего фактора
NZ568769A (en) Human monoclonal antibodies against CD20
EA200300050A1 (ru) Гликопептидфосфонатные производные
ATE293989T1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
ATE172742T1 (de) Peptide mit wachstumshormonfreisetzender aktivität
DE69942753D1 (de) Peptidantagonist von Zonulin und dessen Verwendung
DE69434181D1 (de) Therapeutische Peptid Derivate
EA200300856A1 (ru) Долгоживущие производные рилизинг-фактора гормона роста
EA200100780A1 (ru) Антагонисты tweak и рецептора tweak и их использование для лечения иммунологических заболеваний
HUP0002704A2 (hu) Az 5. és a 6. helyzetben módosított GnRH antagonisták
DE60033649D1 (de) Verbindungen und therapeutische methoden
ES2150901T3 (es) Antagonistas de hormonas del crecimiento.
ES2061908T3 (es) Antagonistas competitivos de gonadoliberina.
EA200000168A1 (ru) Фармацевтическая композиция, снижающая продуцирование белка мср-1
BR0207451A (pt) Derivados de quinolina, isoquinolina e ftalazina como antagonistas do hormÈnio liberador de gonadotropina
UA22667A (uk) Склад "фітодент" для лікування захворювань порожнини рота та горла
ECSP972344A (es) Proteinas antiobesidad

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties